CTLA4 and melanoma: Engeland et al. tested the efficacy of attenuated measles virus (MV) vectors, encoding for antibodies against PD-L1 (MVaPDL1) or CTLA-4 (MVaCTLA4), against murine model of melanoma (B16-CD20).